Bladder bacteria swap eases painful condition in early trial
NCT ID NCT07530627
First seen Apr 20, 2026 · Last updated May 15, 2026 · Updated 6 times
Summary
This study tested a new treatment called urinary microbiota transplantation (UMT) for people with a rare bladder condition (cystitis glandularis) linked to pelvic lipomatosis. 110 adults who had not improved with standard care received weekly UMT infusions for one month. The treatment reduced symptoms like pain and frequent urination by lowering a harmful fat-like substance in the bladder, without needing lifelong medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PELVIC LIPOMATOSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University First Hospital
Beijing, Beijing Municipality, 100034, China
Conditions
Explore the condition pages connected to this study.